Fusion proteins for the treatment of CNS
Details for Australian Patent Application No. 2004247025 (hide)
International Classifications
Event Publications
1 December 2005 PCT application entered the National Phase
PCT publication WO2004/110359 Priority application(s): WO2004/110359
8 December 2005 Amendment Made
The nature of the amendment is: Add priority details 60/471.240 16 May 2003 US 2004251040 University of Utah Research Foundation The nature of the amendment is: Amend the invention title to read Anti-adhesion composites and methods of use thereof 2004251042 Depuy Spine, Inc. The nature of the amendment is as shown in the statement(s) filed 09 Nov 2005
23 June 2011 Application Accepted
Published as AU-B-2004247025
30 June 2011 Corrigenda
Applications Accepted - Name Index Under the name Acorda Therapeutics, Inc., Application No. 2004247025, under INID (31) insert 60/471,240, under INID insert 16 May 2003, under INID insert US
20 October 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004247026-Proteoglycan degrading mutants for treatment of CNS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser